Fri, Jul 17, 2020

Medical Devices Risk to Tackle Coronavirus

In a recent webcast, Kroll examined the impact COVID-19 has had on supply chains and explored some of the challenges medical device manufacturers and supply chains are facing.

Key Discussion Points

  • Companies are being forced to abruptly shift to new business models in ways that significantly alter their risk and resilience.
  • Supply chains, already a target of economic nationalism in some countries, now face new questions about risk concentration.
  • Revenues are falling globally under twin blows of production disruptions and weakening demand with a ripple effect among third party vendors and contractors.
Webcast Replay | Medical Devices Risk to Tackle Coronavirus

Download Webcast Slides

For any questions about the webcast, or to get in touch with an expert about managing and mitigating your medical devices risk, please email us.

Read more compliance news and thought leadership on our Compliance Risk and Diligence article feed.



Compliance Risk and Diligence

The Kroll Investigations, Diligence and Compliance team partners with clients to anticipate, detect and manage regulatory and reputational risks associated with global ethics and compliance obligations.

Compliance Program Consulting

Kroll is trusted by companies worldwide to help establish policies and programs aimed toward preventing fraud and complying with anti-money laundering (AML) and anti-bribery and corruption regulations.

AML Compliance Due Diligence

Kroll helps clients navigate the complexities of today’s regulatory environment through a broad suite of anti-money laundering compliance screening and due diligence offers.


Due Diligence Wizard Tool

Determine which due diligence product best fits your needs.

Compliance Portal

Your Process. Our Technology.

Supply Chain Risk Management Services

Helping clients build resiliency by proactively identifying, assessing, mitigating and monitoring their hidden supply chain risks.